Home » Topics » BioWorld Science

BioWorld Science
RSS

FORMA Therapeutics synthesizes USP9X inhibitors

July 22, 2020

FutureChem identifies FOLH1-binding radiopharmaceuticals

July 22, 2020

CytoDyn presents safety data from phase II COVID-19 trial of leronlimab

July 22, 2020

Newave Pharmaceutical divulges Bcl-2 inhibitors

July 22, 2020

Agios Pharmaceuticals presents Mat2A inhibitors

July 22, 2020

Discovery of novel anti-ILT2 monoclonal antibody, BND-22

July 22, 2020

Novel engineered mouse model of GvHD

July 22, 2020

First-in-human study examines CAR-37 T cells in relapsed/refractory CD37+ hematologic malignancies

July 22, 2020

TIE2 IgG monoclonal agonistic antibody PMC-403 stabilizes vessels to enhance antitumor therapy

July 22, 2020

AZP-2006 studied in phase II for progressive supranuclear palsy

July 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...